CA Stock MarketDetailed Quotes

MDP Medexus Pharmaceuticals Inc

Watchlist
  • 2.700
  • +0.120+4.65%
15min DelayMarket Closed Sep 5 16:00 ET
66.22MMarket Cap49.09P/E (TTM)

Medexus Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Total revenue
-13.54%27.28M
4.59%113.05M
-9.33%25.96M
-12.25%25.21M
9.54%30.33M
36.92%31.56M
40.93%108.1M
41.31%28.63M
35.08%28.73M
54.66%27.69M
Operating revenue
-13.54%27.28M
4.59%113.05M
-9.33%25.96M
-12.25%25.21M
9.54%30.33M
36.92%31.56M
40.93%108.1M
41.31%28.63M
35.08%28.73M
54.66%27.69M
Cost of revenue
-13.05%12.45M
11.41%53.54M
-7.04%12.66M
-2.19%12.52M
21.71%14.05M
41.72%14.32M
23.94%48.06M
34.16%13.62M
31.01%12.8M
35.58%11.54M
Gross profit
-13.94%14.84M
-0.87%59.51M
-11.40%13.31M
-20.34%12.69M
0.83%16.28M
33.17%17.24M
58.30%60.04M
48.48%15.02M
38.54%15.93M
71.96%16.14M
Operating expense
-15.27%10.51M
-9.35%46.73M
-14.03%10.48M
-12.13%11.13M
-7.90%12.72M
-3.76%12.4M
2.48%51.55M
12.71%12.19M
7.23%12.66M
1.62%13.82M
Selling and administrative expenses
-16.24%8.7M
-8.84%38.44M
-12.27%8.64M
-11.95%9.12M
-8.67%10.29M
-2.85%10.39M
9.24%42.16M
20.84%9.85M
10.41%10.35M
8.16%11.26M
-Selling and marketing expense
-28.94%2.09M
-7.13%10.58M
-19.97%2.12M
1.52%2.61M
-3.74%2.91M
-6.62%2.93M
19.78%11.39M
50.28%2.65M
25.48%2.57M
28.40%3.03M
-General and administrative expense
-11.24%6.62M
-9.47%27.86M
-9.43%6.52M
-16.40%6.51M
-10.48%7.37M
-1.28%7.46M
5.80%30.77M
12.70%7.2M
6.20%7.78M
2.25%8.24M
Research and development costs
-10.62%1.74M
-10.99%8.04M
-21.73%1.78M
-12.17%1.95M
-3.63%2.37M
-6.75%1.95M
-20.13%9.03M
-11.78%2.27M
-5.09%2.22M
-20.73%2.46M
Depreciation amortization depletion
1.72%59K
-28.90%251K
-11.76%60K
-32.22%61K
-26.53%72K
-40.21%58K
-11.31%353K
-23.60%68K
-3.23%90K
13.95%98K
-Depreciation and amortization
1.72%59K
-28.90%251K
-11.76%60K
-32.22%61K
-26.53%72K
-40.21%58K
-11.31%353K
-23.60%68K
-3.23%90K
13.95%98K
Operating profit
-10.54%4.33M
50.63%12.79M
-0.07%2.83M
-52.08%1.57M
52.60%3.55M
7,834.43%4.84M
168.59%8.49M
503.28%2.83M
1,169.28%3.27M
155.36%2.33M
Net non-operating interest income (expenses)
52.27%-2.03M
1.78%-13.36M
38.43%-2.22M
25.23%-2.66M
-28.42%-4.23M
-35.12%-4.26M
-11.31%-13.61M
-16.25%-3.61M
-12.41%-3.55M
-7.19%-3.29M
Non-operating interest expense
-52.27%2.03M
-1.78%13.36M
-38.43%2.22M
-25.23%2.66M
28.42%4.23M
35.12%4.26M
11.31%13.61M
16.25%3.61M
12.41%3.55M
7.19%3.29M
Other net income (expenses)
-233.44%-399K
798.68%683K
-51.19%389K
143.09%293K
81.10%-298K
-80.53%299K
-99.63%76K
300.50%797K
-130.60%-680K
-110.58%-1.58M
Gain on sale of security
-114.38%-43K
-109.83%-83K
-148.15%-377K
195.13%293K
75.06%-298K
-80.88%299K
-95.97%844K
272.47%783K
-113.66%-308K
-107.62%-1.2M
Special income (charges)
---356K
199.74%766K
5,371.43%766K
--0
--0
--0
-368.29%-768K
-97.86%14K
-1,027.27%-372K
51.28%-382K
-Less:Restructuring and mergern&acquisition
--356K
-315.36%-1.65M
-11,714.29%-1.65M
--0
--0
--0
148.42%768K
99.42%-14K
1,027.27%372K
-51.28%382K
-Less:Impairment of capital assets
----
--888K
----
----
----
----
--0
----
----
----
Income before tax
114.93%1.9M
102.10%106K
8,150.00%990K
17.19%-795K
61.71%-973K
156.96%884K
-31.96%-5.04M
100.33%12K
22.83%-960K
-133.35%-2.54M
Income tax
-124.46%-57K
105.11%320K
103.33%228K
-147.71%-261K
-36.51%120K
251.30%233K
-565.46%-6.26M
-507.87%-6.84M
681.91%547K
107.49%189K
Earnings from equity interest net of tax
Net income
200.61%1.96M
-117.53%-214K
-88.89%762K
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
-126.91%-2.73M
Net income continuous operations
200.61%1.96M
-117.53%-214K
-88.89%762K
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
-126.91%-2.73M
Noncontrolling interests
Net income attributable to the company
200.61%1.96M
-117.53%-214K
-88.89%762K
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
-126.91%-2.73M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
200.61%1.96M
-117.53%-214K
-88.89%762K
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
-126.91%-2.73M
Diluted earnings per share
166.67%0.08
-116.67%-0.01
-88.24%0.04
71.43%-0.02
64.29%-0.05
142.86%0.03
140.00%0.06
225.93%0.34
0.00%-0.07
-126.42%-0.14
Basic earnings per share
166.67%0.08
-116.67%-0.01
-88.24%0.04
71.43%-0.02
64.29%-0.05
142.86%0.03
140.00%0.06
225.93%0.34
0.00%-0.07
-126.92%-0.14
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Total revenue -13.54%27.28M4.59%113.05M-9.33%25.96M-12.25%25.21M9.54%30.33M36.92%31.56M40.93%108.1M41.31%28.63M35.08%28.73M54.66%27.69M
Operating revenue -13.54%27.28M4.59%113.05M-9.33%25.96M-12.25%25.21M9.54%30.33M36.92%31.56M40.93%108.1M41.31%28.63M35.08%28.73M54.66%27.69M
Cost of revenue -13.05%12.45M11.41%53.54M-7.04%12.66M-2.19%12.52M21.71%14.05M41.72%14.32M23.94%48.06M34.16%13.62M31.01%12.8M35.58%11.54M
Gross profit -13.94%14.84M-0.87%59.51M-11.40%13.31M-20.34%12.69M0.83%16.28M33.17%17.24M58.30%60.04M48.48%15.02M38.54%15.93M71.96%16.14M
Operating expense -15.27%10.51M-9.35%46.73M-14.03%10.48M-12.13%11.13M-7.90%12.72M-3.76%12.4M2.48%51.55M12.71%12.19M7.23%12.66M1.62%13.82M
Selling and administrative expenses -16.24%8.7M-8.84%38.44M-12.27%8.64M-11.95%9.12M-8.67%10.29M-2.85%10.39M9.24%42.16M20.84%9.85M10.41%10.35M8.16%11.26M
-Selling and marketing expense -28.94%2.09M-7.13%10.58M-19.97%2.12M1.52%2.61M-3.74%2.91M-6.62%2.93M19.78%11.39M50.28%2.65M25.48%2.57M28.40%3.03M
-General and administrative expense -11.24%6.62M-9.47%27.86M-9.43%6.52M-16.40%6.51M-10.48%7.37M-1.28%7.46M5.80%30.77M12.70%7.2M6.20%7.78M2.25%8.24M
Research and development costs -10.62%1.74M-10.99%8.04M-21.73%1.78M-12.17%1.95M-3.63%2.37M-6.75%1.95M-20.13%9.03M-11.78%2.27M-5.09%2.22M-20.73%2.46M
Depreciation amortization depletion 1.72%59K-28.90%251K-11.76%60K-32.22%61K-26.53%72K-40.21%58K-11.31%353K-23.60%68K-3.23%90K13.95%98K
-Depreciation and amortization 1.72%59K-28.90%251K-11.76%60K-32.22%61K-26.53%72K-40.21%58K-11.31%353K-23.60%68K-3.23%90K13.95%98K
Operating profit -10.54%4.33M50.63%12.79M-0.07%2.83M-52.08%1.57M52.60%3.55M7,834.43%4.84M168.59%8.49M503.28%2.83M1,169.28%3.27M155.36%2.33M
Net non-operating interest income (expenses) 52.27%-2.03M1.78%-13.36M38.43%-2.22M25.23%-2.66M-28.42%-4.23M-35.12%-4.26M-11.31%-13.61M-16.25%-3.61M-12.41%-3.55M-7.19%-3.29M
Non-operating interest expense -52.27%2.03M-1.78%13.36M-38.43%2.22M-25.23%2.66M28.42%4.23M35.12%4.26M11.31%13.61M16.25%3.61M12.41%3.55M7.19%3.29M
Other net income (expenses) -233.44%-399K798.68%683K-51.19%389K143.09%293K81.10%-298K-80.53%299K-99.63%76K300.50%797K-130.60%-680K-110.58%-1.58M
Gain on sale of security -114.38%-43K-109.83%-83K-148.15%-377K195.13%293K75.06%-298K-80.88%299K-95.97%844K272.47%783K-113.66%-308K-107.62%-1.2M
Special income (charges) ---356K199.74%766K5,371.43%766K--0--0--0-368.29%-768K-97.86%14K-1,027.27%-372K51.28%-382K
-Less:Restructuring and mergern&acquisition --356K-315.36%-1.65M-11,714.29%-1.65M--0--0--0148.42%768K99.42%-14K1,027.27%372K-51.28%382K
-Less:Impairment of capital assets ------888K------------------0------------
Income before tax 114.93%1.9M102.10%106K8,150.00%990K17.19%-795K61.71%-973K156.96%884K-31.96%-5.04M100.33%12K22.83%-960K-133.35%-2.54M
Income tax -124.46%-57K105.11%320K103.33%228K-147.71%-261K-36.51%120K251.30%233K-565.46%-6.26M-507.87%-6.84M681.91%547K107.49%189K
Earnings from equity interest net of tax
Net income 200.61%1.96M-117.53%-214K-88.89%762K64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M-126.91%-2.73M
Net income continuous operations 200.61%1.96M-117.53%-214K-88.89%762K64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M-126.91%-2.73M
Noncontrolling interests
Net income attributable to the company 200.61%1.96M-117.53%-214K-88.89%762K64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M-126.91%-2.73M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 200.61%1.96M-117.53%-214K-88.89%762K64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M-126.91%-2.73M
Diluted earnings per share 166.67%0.08-116.67%-0.01-88.24%0.0471.43%-0.0264.29%-0.05142.86%0.03140.00%0.06225.93%0.340.00%-0.07-126.42%-0.14
Basic earnings per share 166.67%0.08-116.67%-0.01-88.24%0.0471.43%-0.0264.29%-0.05142.86%0.03140.00%0.06225.93%0.340.00%-0.07-126.92%-0.14
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg